Primary Immune Thrombocytopenia and Thrombopoietin Receptor Agonists: Feasibilities of Treatment Discontinuation upon Achieving Stable Complete Platelet Response

Aim. To assess the stability of clinical remission in patients with primary immune thrombocytopenia (ITP) after withdrawal of thrombopoietin receptor agonists (TPO-RAs). Materials & Methods. The study enrolled 456 patients with primary ITP who received second- and subsequent-line TPO-RA treatment...

ver descrição completa

Detalhes bibliográficos

Principais autores:	O. Yu. Vinogradova, M. M. Pankrashkina, Anna Leonidovna Neverova, M. V. Chernikov, L. A. Mukha, D. I. Shikhbabaeva, V. V. Ptushkin
Formato:	Artigo
Idioma:	Russo
Publicado em:	Practical Medicine Publishing House 2023-09-01
Colecção:	Клиническая онкогематология
Assuntos:	primary immune thrombocytopenia itp thrombopoietin receptor agonists romiplostim eltrombopag
Acesso em linha:	https://bloodjournal.ru/index.php/coh/article/view/54
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!